Loading...
Market
Will Sarepta Therapeutics stock price drop by more than 10% following the censorship incident by August 31, 2024?
4
Resolution / Starting Odds
Yes • 50%
No • 50%
Stock price data from financial markets
Story
Sarepta ($SRPT) Faces Backlash for Censoring Critical Duchenne Advocacy Video
Jul 29, 2024, 12:18 PM
Sarepta Therapeutics ($SRPT) has come under scrutiny for demanding a prominent Duchenne muscular dystrophy patient advocacy organization censor a video that contained pointed criticism of its new gene therapy. The video, which was critical of Sarepta's approach and its impact on patients, was subsequently taken down. This incident, reported by STAT, has raised questions about the relationship between drugmakers and patient advocacy groups. The news has sparked discussions about the influence pharmaceutical companies exert over advocacy organizations and the potential implications for patient care and transparency.
View original story
Similar markets
Yes • 50%
No • 50%
Below $166 • 33%
$166 to $213 • 33%
Above $213 • 34%
Below $150 • 33%
$150 - $200 • 33%
Above $200 • 33%
Stock price up 0-10% • 33%
Stock price up 10-20% • 33%
Stock price up more than 20% • 34%